DIM.PA vs. CUV.AX

Last updated Jun 4, 2026

DIM.PA (Sartorius Stedim Biotech SA) and CUV.AX (Clinuvel Pharmaceuticals Limited) are both stocks. Both are in the Healthcare sector — DIM.PA in Medical Instruments & Supplies, CUV.AX in Biotechnology. Over the past 10 years, DIM.PA returned 11.80%/yr vs 6.44%/yr for CUV.AX. At a 0.09 correlation, their price movements are largely independent.

Performance

DIM.PA vs. CUV.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Sartorius Stedim Biotech SA (DIM.PA) and Clinuvel Pharmaceuticals Limited (CUV.AX). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

DIM.PA is traded in EUR, while CUV.AX is traded in AUD. To make them comparable, the CUV.AX values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, DIM.PA achieves a -15.61% return, which is significantly higher than CUV.AX's -23.40% return. Over the past 10 years, DIM.PA has outperformed CUV.AX with an annualized return of 11.80%, while CUV.AX has yielded a comparatively lower 6.44% annualized return.

DIM.PA

• 1D: 0.06%
• 1M: 13.50%
• YTD: -15.61%
• 6M: -17.65%
• 1Y: -6.53%
• 3Y*: -12.36%
• 5Y*: -12.20%
• 10Y*: 11.80%

CUV.AX

• 1D: -2.18%
• 1M: -4.38%
• YTD: -23.40%
• 6M: -21.16%
• 1Y: -3.11%
• 3Y*: -21.27%
• 5Y*: -21.38%
• 10Y*: 6.44%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DIM.PA vs. CUV.AX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DIM.PA Sartorius Stedim Biotech SA	-15.61%	11.71%	-21.00%	-20.45%	-37.08%	65.98%	97.46%	69.96%	45.77%	1.26%
CUV.AX Clinuvel Pharmaceuticals Limited	-23.40%	-1.36%	-26.73%	-28.23%	-20.57%	23.80%	-20.90%	60.29%	109.09%	4.48%

Correlation

The correlation between DIM.PA and CUV.AX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.13
Correlation (All Time) Calculated using the full available price history since Aug 27, 2007	0.09

Return for Risk

DIM.PA vs. CUV.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DIM.PA

DIM.PA Risk / Return Rank: 33
DIM.PA Sharpe Ratio Rank: 34
DIM.PA Sortino Ratio Rank: 31
DIM.PA Omega Ratio Rank: 31
DIM.PA Calmar Ratio Rank: 35
DIM.PA Martin Ratio Rank: 34

CUV.AX

CUV.AX Risk / Return Rank: 31
CUV.AX Sharpe Ratio Rank: 31
CUV.AX Sortino Ratio Rank: 30
CUV.AX Omega Ratio Rank: 30
CUV.AX Calmar Ratio Rank: 32
CUV.AX Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DIM.PA vs. CUV.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sartorius Stedim Biotech SA (DIM.PA) and Clinuvel Pharmaceuticals Limited (CUV.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DIM.PA	CUV.AX	Difference
Sharpe ratio: Return per unit of total volatility	-0.17	-0.07	-0.10
Sortino ratio: Return per unit of downside risk	0.02	0.22	-0.19
Omega ratio: Gain probability vs. loss probability	1.00	1.03	-0.02
Calmar ratio: Return relative to maximum drawdown	-0.20	-0.11	-0.10
Martin ratio: Return relative to average drawdown	-0.41	-0.19	-0.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DIM.PA vs. CUV.AX - Sharpe Ratio Comparison

The current DIM.PA Sharpe Ratio is -0.17, which is lower than the CUV.AX Sharpe Ratio of -0.07. The chart below compares the historical Sharpe Ratios of DIM.PA and CUV.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DIM.PA	CUV.AX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.17	-0.07	-0.10
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.28	-0.45	+0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.30	0.12	+0.18
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	0.03	+0.52

Drawdowns

DIM.PA vs. CUV.AX - Drawdown Comparison

The maximum DIM.PA drawdown since its inception was -76.82%, smaller than the maximum CUV.AX drawdown of -89.08%. Use the drawdown chart below to compare losses from any high point for DIM.PA and CUV.AX.

Drawdown Indicators

	DIM.PA	CUV.AX	Difference
Max Drawdown Largest peak-to-trough decline	-76.82%	-89.08%	+12.26%
Max Drawdown (1Y) Largest decline over 1 year	-31.79%	-29.33%	-2.46%
Max Drawdown (3Y) Largest decline over 3 years	-48.78%	-58.06%	+9.28%
Max Drawdown (5Y) Largest decline over 5 years	-73.20%	-80.39%	+7.19%
Max Drawdown (10Y) Largest decline over 10 years	-73.20%	-80.71%	+7.51%
Current Drawdown Current decline from peak	-67.20%	-80.05%	+12.85%
Average Drawdown Average peak-to-trough decline	-24.94%	-55.43%	+30.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.77%	16.09%	-0.32%

Volatility

DIM.PA vs. CUV.AX - Volatility Comparison

Sartorius Stedim Biotech SA (DIM.PA) and Clinuvel Pharmaceuticals Limited (CUV.AX) have volatilities of 8.62% and 8.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DIM.PA	CUV.AX	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.62%	8.69%	-0.07%
Volatility (6M) Calculated over the trailing 6-month period	30.20%	30.75%	-0.55%
Volatility (1Y) Calculated over the trailing 1-year period	38.09%	44.45%	-6.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.72%	47.64%	-3.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	38.58%	53.49%	-14.91%

Dividends

DIM.PA vs. CUV.AX - Dividend Comparison

DIM.PA's dividend yield for the trailing twelve months is around 0.39%, less than CUV.AX's 0.57% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CUV.AX Clinuvel Pharmaceuticals Limited	0.57%	0.40%	0.41%	0.31%	0.18%	0.09%	0.11%	0.09%	0.11%	0.00%	0.00%	0.00%
DIM.PA Sartorius Stedim Biotech SA	0.39%	0.33%	0.37%	0.60%	0.42%	0.14%	0.12%	0.39%	0.53%	0.70%	0.56%	0.37%

Financials

Frequently Asked Questions

Can I hold both DIM.PA and CUV.AX in my portfolio?

DIM.PA and CUV.AX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.